Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Sernova Biotherapeutics Inc (OP:SEOVF)

0.0947 -0.0001 (-0.11%)
Streaming Delayed Price Updated: 2:08 PM EST, Dec 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 33,000
Open 0.0947
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0948
Today's Range 0.0947 - 0.0947
52wk Range 0.0867 - 0.1816
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
Issued on behalf of Avant Technologies Inc. 
From USA News Group
Via GlobeNewswire
Sernova Announces Key New Executive Appointments
Experienced leadership team positions company to advance Cell Pouch™ bio-hybrid organ programs. 
Via TheNewswire.com

Performance

YTD
-39.1%
-39.1%
1 Month
-1.8%
-1.8%
3 Month
-25.8%
-25.8%
6 Month
-21.4%
-21.4%
1 Year
-39.2%
-39.2%

More News

Read More
News headline image
Sernova to Present at the 2024 Cell & Gene Meeting on the Mesa
Via NewMediaWire
Sernova Provides Positive Clinical and Platform Portfolio Update
Via TheNewswire.com
Sernova Announces Peer Reviewed Publication Demonstrating Safety and Efficacy of a Novel Cell Pouch Cell Therapy Approach for Treatment of Severe Hemophilia A
Via TheNewswire.com
Sernova to Present Corporate Update at Canaccord Genuity's 41st Annual Growth Conference
Via TheNewswire.com
Sernova Announces 2021 Annual Meeting Results: Shareholders Approve Resolutions with Overwhelming Majority
Via TheNewswire.com
Industry Veteran Frank Shannon Joins Sernova as VP Clinical Development and Regulatory Affairs
Via TheNewswire.com
Sernova's Principal Investigator Presents Interim Data and Positive Patient Outcomes of Phase I/II T1D Study at the American Diabetes Association 81st Scientific Sessions
Via TheNewswire.com
Sernova's Principal Investigator Presents Positive New Data from Ongoing Type 1 Diabetes (T1D) Clinical Trial at ATC 2021 Virtual Connect Conference
Via TheNewswire.com
Sernova Announces American Transplant Congress 2021 Virtual Connect Abstract Presentation
Via TheNewswire.com
Sernova to Present at Global Partnership Family Office -- HealthCare & Biotechnology TSX Showcase
Via TheNewswire.com
Sernova Announces the Nomination of Seasoned Pharma Executive Dr. Mohammad Azab to its Board of Directors
Via TheNewswire.com
Topics Retirement
Sernova KOL Event Highlights Novel Cell Therapy Approach for the Potential Treatment of Thyroid Disease
Via TheNewswire.com
Sernova to Host a Virtual Key Opinion Leader Event on Thyroid Disease and the Potential for its Cell Therapy as a Novel Treatment Approach
Via TheNewswire.com
Sernova Appoints Internationally Renowned Thyroid Disease Expert Dr. Sam Wiseman to its Scientific Advisory Board
Via TheNewswire.com

Frequently Asked Questions

Is Sernova Biotherapeutics Inc publicly traded?
Yes, Sernova Biotherapeutics Inc is publicly traded.
What exchange does Sernova Biotherapeutics Inc trade on?
Sernova Biotherapeutics Inc trades on the OTC Traded
What is the ticker symbol for Sernova Biotherapeutics Inc?
The ticker symbol for Sernova Biotherapeutics Inc is SEOVF on the OTC Traded
What is the current price of Sernova Biotherapeutics Inc?
The current price of Sernova Biotherapeutics Inc is 0.0947
When was Sernova Biotherapeutics Inc last traded?
The last trade of Sernova Biotherapeutics Inc was at 12/19/25 02:08 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.